Company Update (NASDAQ:ALXN): Alexion Reports Second Quarter 2015 Results

[Business Wire] – Alexion Pharmaceuticals, Inc. today announced financial results for the second quarter of 2015. Net product sales of Soliris® grew to $636 million, a 24% increase, compared to $512.5 million for . . . → Read More: Company Update (NASDAQ:ALXN): Alexion Reports Second Quarter 2015 Results Similar Articles: Market Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015 Market Update (NASDAQ:ALXN): Alexion Reports First Quarter 2015 Results Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report First Quarter 2015 Results on Thursday, April 23, 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.